IMMUNITYBIO, INC. Other Non-Current Liabilities
IMMUNITYBIO, INC. (IBRX) had Other Non-Current Liabilities of $510.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-04
- 2026-06-30: Other Liabilities, Noncurrent $510.00K.
- 2026-03-31: Other Liabilities, Noncurrent $472.00K.
- 2025-12-31: Other Liabilities, Noncurrent $424.00K.
- 2025-09-30: Other Liabilities, Noncurrent $702.00K.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $510.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $472.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $424.00K 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $702.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $710.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $370.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $319.00K 10-K · filed 2026-02-23 | $639.00K 10-K · filed 2025-03-03 |
| 2024-09-30 | $705.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $704.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.28M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.11M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $467.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $473.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $462.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $457.00K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $569.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $290.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $288.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $411.00K 10-K · filed 2023-03-01 | $249.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $905.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $920.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $891.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.03M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $1.41M 8-K/A · filed 2021-04-22 | |
| 2018-12-31 | $0.00 10-K · filed 2019-03-13 | |
| 2018-09-30 | $24.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $44.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $65.00K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $255.00K 10-K · filed 2019-03-13 | $89.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $341.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $370.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $216.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $240.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $22.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $26.00K 10-Q · filed 2016-08-15 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |